¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"beta learning"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® learning ÇÑ±Û ÇнÀ
¼³¸í   
  ¿¬½À ¹× °æÇèÀÇ °á°ú·Î, Çൿ¿¡ ³ªÅ¸³ª´Â ¹Ý¿µ±¸ÀûÀΠº¯È­¸¦ °¡¸®Å°´Â ÀϹÝÀû ¿ë¾î. ÇൿÀÇ º¯È­´Â °üÂûÇÒ ¼ö Àִ Çö»óÀ¸·Î¼­ Æ¯È÷ À̸¦ ¼öÇà(performance)À̶ó°í ºÎ¸£´Â °æ¿ì°¡ Àִµ¥, ±×·¯ÇÑ °æ¿ì¿¡ ±× Çö»óÀÇ ¹èÈÄ¿¡ °¡¼³ÀûÀ¸·Î ±¸¼ºµÈ ½Àµæ(acquisition)ÀÇ °úÁ¤À» ÁöĪÇϰԠµÈ´Ù.
¿µ¹® learning disorder ÇÑ±Û ÇнÀÀå¾Ö
¼³¸í   
  Áö´ÉÀº Á¤»óÀÌÁö¸¸ µè±â, ¸»Çϱâ, Àбâ, ¾²±â, Ã߸® ¶Ç´Â °è»ê´É·Â¿¡ ½É°¢ÇÑ ¹®Á¦°¡ ³ªÅ¸³ª´Â ¿©·¯ Àå¾ÖµéÀ» ÀÏÄ´ ¿ë¾î. À̷ΠÀÎÇØ Çо÷¼ºÀû ¹× Àڽۨ ÀúÇÏ, ´ëÀΰü°è¿¡¼­µµ »ç±³ ´É·ÂÀÌ ¹Ì¼÷ÇÏ¿© ÀÏ»ó»ýȰÀÇ ¸ðµç ¸é¿¡¼­ ¹®Á¦°¡ ³ªÅ¸³­´Ù. ¼ºÀα⠻çȸÀûÀÀ·Â¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÇൿÀå¾Ö, ÁÖÀǷ°áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö µî°ú µ¿¹ÝµÇ¾î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ±× À¯º´·üÀº ³·°Ô´Â 1.7%, ³ô°Ô´Â 30% Á¤µµ·Î ÃßÁ¤Çϰí ÀÖÁö¸¸ Çе¿±â ¾Æµ¿ÀÇ ¾à 3~9%°¡ ÀÌ Àå¾Ö¸¦ °®°í Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±âÃÊÇнÀ±â´É°Ë»ç¸¦ ÅëÇÏ¿© Áø´ÜÇÑ´Ù. ÇнÀÀÇ ±âȸ³ª ±³À°ÀûÀΠÀÚ±ØÀÌ ºÎÁ·ÇÑ °æ¿ì, ÁýÁ߷ ºÎÁ·, ¿ì¿ïÁõ-ºÒ¾È µî Á¤¼­Àû ¹®Á¦, ½Å°æÇÐÀû À̻󿡠ÀÇÇÑ °æ¿ì µîÀÌ ¿øÀÎÀÏ ¼ö ÀÖ´Ù. ÇнÀ°ú °ü·ÃÀÌ Àִ ³ú±â´É°ú ¿¬°üµÈ Æ¯Á¤¿µ¿ª¿¡ °áÇÔÀÌ Àְųª ¹ßÀ°Áö¿¬ ¶Ç´Â Àå¾Ö°¡ Àִ °æ¿ìµµ ¿øÀÎÀÌ µÈ´Ù. ¶ÇÇÑ ºÎ¸ð°¡ Á¶±â¿¡ ÀÚ³àÀÇ ´É·Â°ú Àû¼ºÀ» Àß ¾ËÁö ¸øÇϴ °æ¿ì¿¡µµ ¸¹ÀÌ »ý±ä´Ù.
¿µ¹® beta human chorionic gonadotropin ÇÑ±Û º£Å¸ »ç¶÷À¶¸ð¼º »ý½Ä»ùÀÚ±ØÈ£¸£¸ó
¼³¸í   
  Å¹ݼ¼Æ÷¿¡¼­ ¸¸µé¾îÁö´Â È£¸£¸ó. ±â´ÉÀº ÀÓ½ÅÀÇ Ãʱ⿡ È²Ã¼(¿ø·¡ ³­ÀÚ¸¦ ½Î°í ÀÖ´ø ¼¼Æ÷µéÀÌ ¹è¶õÀÌ ÀϾ¼­ ³­ÀÚ°¡ ºüÁ®³ª°£ ÈÄ ÁÖ¸Ó´Ï ¸ð¾çÀ» ÀÌ·é °Í. ÀÓ½ÅÃʱ⿡ ÀÓ½ÅÀÇ À¯Áö¿¡ ÇÊ¿äÇѠȣ¸£¸óÀ» »ý¼ºÇÑ´Ù)ÀÇ À¯Áö¿¡ ±â¿©Çϰí, Å¾ÆÀÇ °íȯÁ¶Á÷¿¡¼­ ³²¼ºÈ£¸£¸óÀÌ ºÐºñµÇ´Â °ÍÀ» ÃËÁø½ÃŲ´Ù. ¶Ç À̰ÍÀº ÀÓ½ÅÃʱâÀÇ ÀÓ»êºÎÀÇ ¼Òº¯¿¡¼­ ¸¹Àº ¾çÀÌ °ËÃâµÇ¹Ç·Î À̰ÍÀ» ÀÌ¿ëÇØ¼­ ÀÓ½ÅÀÇ ¿©ºÎ¸¦ ¼Õ½±°Ô Á¶»çÇÒ ¼ö°¡ ÀÖ´Ù.
¿µ¹® beta ray ÇÑ±Û º£Å¸¼±
¼³¸í   
  ¹æ»ç¼º ¿øÀÚÇÙÀÌ ¥âºØ±«ÇÔ¿¡ µû¶ó ¹æÃâµÇ´Â ¹æ»ç¼±. ¿øÀÚ¿¡ Á¤»óº¸´Ù ¸¹°Å³ª ÀûÀº Áß¼ºÀÚ³ª ¾çÀÚ¸¦ °¡Áö°í Àִ °æ¿ì¿¡´Â ¿øÀÚ°¡ ¾ÈÁ¤µÇ±â À§ÇÏ¿© ºØ±«°¡ ¼¼°¡Áö ¹æ¹ýÀ¸·Î »ý±ä´Ù. ÀÌÁß Áß¼ºÀÚ°¡ ÇϳªÀÇ ÀüÀÚ¸¦ ³»°í ¾ç¼ºÀÚ°¡ µÇ´Â º¯È­¸¦ °ÅÄ¡¸é¼­ ³ª¿À´Â ÀüÀÚ¼±ÀÌ´Ù. ±× ½Çü´Â °í¼ÓÀÇ ÀüÀÚ ¶Ç´Â ¾çÀüÀÚÀ̸ç ÃÖ´ë ¿¡³ÊÁö´Â 105-107eV. Åõ°ú·Â ¹× ÀÌ¿ÂÈ­ ÀÛ¿ëÀº ¥á¼±°ú ¥ã¼±ÀÇ Áß°£ Á¤µµÀÌ´Ù.
¿µ¹® beta-blocker ÇÑ±Û º£Å¸Â÷´ÜÁ¦
¼³¸í   
  º£Å¸-¼ö¿ëü(1°ú 2¿¡ °ü°è¾øÀÌ)ÀÇ ±â´ÉÀ» ¾ïÁ¦½Ã۴ ¾à¹°·Î ÀÌ ¼ö¿ëü°¡ ¸Å°³ÇÏ¿© »ý±â´Â ½ÅüÀÇ º¯È­¸¦ ¾ïÁ¦ÇÑ´Ù. PropranololÀÌ ÁÁÀº ¿¹ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta cell
    º£Å¸¼¼Æ÷
  • beta counting
    º£Å¸°è¼ö
  • beta emitter
    º£Å¸¹æÃâü
  • beta error
    º£Å¸¿À·ù, Á¦2Çü¿À·ù
  • beta hemolysis
    º£Å¸¿ëÇ÷, ¿ÏÀü¿ëÇ÷
  • beta particle
    º£Å¸ÀÔÀÚ
  • beta ray
    º£Å¸¼±
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈ­È¿¼Ò
  • beta-carotene
    º£Å¸Ä«·Îƾ
  • beta-lactam
    º£Å¸¶ôŽ
  • beta-lactamase
    º£Å¸¶ô޾ÆÁ¦
  • beta-lactamase inhibitors
    º£Å¸¶ô޾ÆÁ¦¾ïÁ¦Á¦
  • pre-beta-lipoprotein
    ÇÁ¸®º£Å¸ÁöÁú´Ü¹éÁú
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ
  • conditioned learning
    Á¶°ÇÈ­ÇнÀ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-carotene
    º£Å¸Ä«·Îƾ
  • beta cell
    º£Å¸¼¼Æ÷
  • learning curve
    ÇнÀ°î¼±
  • learning disorder
    ÇнÀÀå¾Ö
  • beta hemolysis
    º£Å¸¿ëÇ÷
  • learning
    ÇнÀ
  • problem based learning
    ¹®Á¦¹ÙÅÁÇнÀ
  • beta ray
    º£Å¸¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta cell
    º£Å¸¼¼Æ÷
  • beta counting
    º£Å¸°è¼ö
  • beta emitter
    º£Å¸¹æÃâ±â
  • beta error
    Á¦ÀÌÁ¾¿À·ù
  • beta hemolysis
    º£Å¸¿ëÇ÷, ¿ÏÀü¿ëÇ÷
  • beta particle
    º£Å¸ÀÔÀÚ
  • beta ray
    º£Å¸¼±
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈ­È¿¼Ò
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ
  • conditioned learning
    Á¶°ÇÈ­ÇнÀ
  • discrimination learning
    ½Äº°ÇнÀ
  • learning disorder
    ÇнÀÀå¾Ö
  • escape learning
    µµÇÇÇнÀ
  • instrumental learning
    µµ±¸ÀûÇнÀ
  • learning
    ÇнÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Learning
    ÇнÀ(ùÊã§)
  • instrumental learning
    µµ±¸Àû ÇнÀ
  • 11-beta-hydroxylase
    11-º£Å¸-¼ö»êÈ­È¿¼Ò, 11-º£Å¸-È÷µå·Ï½Ç¶óÁ¦
  • 3-beta-hydroxysteroid dehydrogenase
    3-º£Å¸-È÷µå·Ï½Ã½ºÅ×·ÎÀ̵å Å»¼ö¼ÒÈ¿¼Ò
  • O-Nitrophenyl-beta-galactoside => ONPG
    O-´ÏÆ®·ÎÆä´Ò-º£Å¸-°¥¶ôÅä½Ãµå
  • acetyl-beta-methylcholine
    ¾Æ¼¼Æ¿-º£Å¸-¸ÞÆ¿Äݸ°
  • alpha/beta (¥á/¥â) ratio
    ¥á/¥â ºñ
  • gamma-delta-beta thalassemia
    °¨¸¶-µ¨Å¸-º£Å¸- ÁöÁßÇØ¼ººóÇ÷
  • hypoglycemia, beta cell tumor
    ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta learning
    º£Å¸ÇнÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-ARK : beta-adrenergic receptor kinase
    º£Å¸-¾Æµå·¹³¯¸°(¼º)¼ö¿ëü ÀλêÈ­È¿¼Ò.
  • associational learning
    ¿¬»óÇнÀ
  • avoidance learning
    ȸÇÇÇнÀ
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ(ìãò±ÞäüåùÊã§)
  • conditioned learning
    Á¶°ÇÈ­ÇнÀ(ðÉËìûùùÊã§)
  • discrimination learning
    ½Äº°ÇнÀ(ÊṴ̀Ëà).
  • escape learning
    µµÇÇÇнÀ(Ô±ù­ùÊã§)
  • instrumental learning
    µµ±¸Àû ÇнÀ
  • learning
    ÇнÀ(ùÊã§).
  • learning disorders
    ÇнÀÀå¾Ö(ùÊã§î¡äô)(º´)
  • maze learning
    ¹Ì·ÎÇнÀ(¡­ùÊã§).
  • respondent learning
    ¹ÝÀÀ¼º ÇнÀ
  • social learning theory
    »çȸÇнÀ°¡¼³
  • social-cognitive learning theory
    »çȸÀÎÁöÇнÀÀÌ·Ð
  • trial-and-error learning
    ½ÃÇàÂø¿ÀÇнÀ(ãËú¼ó¹è¦æßã§).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Beta cell [Insulin cell]
    º£Å¸¼¼Æ÷ [Àν´¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] º£Å¸¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta
    "º£Å¸, (ÔÒ) ¥â"
  • beta adrenergic blocker
    º£Å¸ ¾Æµå·¹³¯¸°ÀÛµ¿(íÂÔÑ) Â÷´ÜÁ¦(ó´Ó¨ð¥)
  • beta adrenergic receptor
    º£Å¸ ¾Æµå·¹³¯¸° ¼ö¿ëü(áôé»ô÷)
  • beta amylase
    º£Å¸ ¾Æ¹Ð·¹À̽º
  • beta bend
    º£Å¸ ±ÁÀ½
  • beta benzyme
    º£Å¸ º¥ÀÚÀÓ
  • beta blocker
    º£Å¸ Â÷´ÜÁ¦(ó´Ó¨ð¥)
  • beta carotene
    º£Å¸ Ä«·ÎÅÙ
  • beta chain
    º£Å¸ »ç½½
  • beta conformation
    º£Å¸ ÀÔü ÇüÅÂ(í¡ô÷ û¡÷¾)
  • beta decay
    º£Å¸ ºØ±«(ÝÚÎÕ)
  • beta emitter
    º£Å¸ ¹æÃâÀÚ(Û¯õóíº)
  • beta error
    º£Å¸ ¿ÀÂ÷(è¦ó¬)
  • beta fraction
    º£Å¸ ºÐȹ(ÝÂüñ)
  • beta galactosidase
    º£Å¸ °¥¶ôÅä½Ãµ¥À̽º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta
    º£Å¸
  • beta blocker
    º£Å¸Â÷´ÜÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HELP Hawaii early learning profile; Health Education Library Program; Health Emergency Loan Program; Heal...
LD labor and delivery; laboratory data; labyrinthine defect; lactate dehydrogenase; laser Doppler; lear...
BB bad breath; bed bath; beta blockade, beta blocker; BioBreeding [rat]; blanket bath; blood bank; bloo...
beta [Greek letter beta] an anomer of a carbohydrate; buffer capacity; carbon separated from a carboxyl by one other carbon i...
BG basal ganglion; basic gastrin; Bender Gestalt [test]; beta-galactosidase; beta-glucuronidase; bicolo...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AVLT Auditory Verbal Learning Test
CVLT California Verbal Learning Test
LD Learning Disabilities
LVQ Learning Vector Quantization
LD Learning disabled
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • beta-aminoisobutyric aciduria ¿äÁß¿¡ º£Å¸-¾Æ¹Ì³ë ¾ÆÀ̼ҴлêÀÌ °úµµ·Î ¹è¼³µÇ´Â °Í. ¾ç¼ºÀÇ À¯Àü¼º ´ë»ç¼º ÀÌ»óÀ¸·Î ÀϾ¸ç ±×¸®°í ƯÁ¤ÇÑ Áúȯ¿¡¼­µµ ³ªÅ¸³­´Ù.

    beta-arrestin

    º£Å¸-¾î·¹½ºÆ¾
  • learning disability
    ÇнÀÀå¾Ö
    Á¤ÀÇ : ÇнÀÀå¾Ö¶õ Á¤»óÀûÀÎ Áö´ÉÀ» °®°í ÀÖ°í, ½Ã·Â°ú û°¢ÀÌ Á¤»óÀûÀ̸ç, ÀûÀýÇÑ ±³À°È¯°æÀ» Á¦°ø¹Þ¾ÒÀ½¿¡µµ ºÒ±¸Çϰí, ƯÁ¤ ¿µ¿ªÀÇ ÇнÀÀÌ ¶Ç·¡ÀÇ Á¤»ó ¾Æµ¿¿¡ ºñÇØ ÇöÀúÈ÷ ¶³¾îÁö´Â °æ¿ì¿¡ Áø´ÜÇÑ´Ù. ´ë°³ Àбâ Àå¾Ö, ¾²±â Àå¾Ö, »ê¼ú Àå¾Ö, ±âŸ ÇнÀ Àå¾Ö·Î ºÐ·ùÇÑ´Ù. ÈçÈ÷ ÁÖÀÇ·Â Àå¾Ö¸¦ µ¿¹ÝÇÑ´Ù. ¿øÀÎ : À¯ÀüÀû ¼ÒÀÎ, ´ë³úÀÇ ±âÁúÀû ÀÌ»ó, ȯ°æÀû ¿äÀÎÀÌ ¿øÀÎÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù. Áõ¼¼ : ´ë°³ Çзɱ⿡ ¹ß°ßµÈ´Ù. a. Àбâ Àå¾Ö : ¾Æµ¿ÀÇ Àб⠴ɷÂÀÌ ¾Æµ¿ÀÇ ¿¬·É, ±³À°ÀÇ ¼öÁØ¿¡ ºñÇØ ÇöÀúÈ÷ ¶³¾îÁø´Ù. Ã¥À» ÀÐÀ» ¶§, ÈçÈ÷ ¿À·ù¸¦ º¸ÀδÙ. ÀÐÀ» ´Ü¾î³ª ´Ü¾îÀÇ ÀϺθ¦ »ý·«Çϰųª ´ëÄ¡, ¿Ö°î ¶Ç´Â Ãß°¡¸¦ Çϸç, Àд ¼Óµµ°¡ ¸Å¿ì ´Ê°í, ÀÐ°í ³ª¼­ ³»¿ëÀ» ±â¾ïÇϰųª ÀÌÇØÇÏÁö ¸øÇÑ´Ù. ƯÈ÷ ¹®ÀåÀÌ ±æ¾îÁö¸é, ¾î·Á¿òÀÌ ´õ ½ÉÇØÁø´Ù. b. ¾²±â Àå¾Ö : ÀÌ Àå¾ÖÀÇ ¾Æµ¿µéÀº ÀúÇгâºÎÅÍ Ã¶ÀÚÀÇ ¿À·ù°¡ ¸¹°Å³ª, ÀÚ½ÅÀÇ »ý°¢À» ±Û·Î Ç¥ÇöÇϴµ¥ À־ ¹®¹ýÀû ¿À·ù¸¦ ÈçÈ÷ ¹üÇÑ´Ù. ±¸µÎÁ¡ »ç¿ë¿¡ À־µµ ¸¹Àº ¿À·ù¸¦ ¹üÇÑ´Ù. ÇгâÀÌ ¿Ã¶ó°¡¸é, ÀÌ·¯ÇÑ ¹®Á¦´Â Á¡Â÷ ´õ ½É°¢ÇØÁ®¼­, ¹®ÀåÀÇ Ã¼°è°¡ ÀâÈ÷Áö ¾Ê°í, ´Ü¾î°¡ Ãß»óÀûÀÌ µÇ¸é, ¾î·Á¿òÀº ´õ ½ÉÇØÁø´Ù. ÀÌ·Î ÀÎÇØ, µî±³¸¦ °ÅºÎÇϰí, ¾²±â ¼÷Á¦¸¦ ÇÏÁö ¾ÊÀ¸·Á Çϸç, ¿ì¿ï Àå¾Ö³ª ¹ÝÇ× Çൿ ¶Ç´Â ºñÇà µîÀÌ ÈÄÀ¯ÁõÀ¸·Î »ý±â±âµµ ÇÑ´Ù. c. »ê¼ú Àå¾Ö : ´ë°³ ÃʵîÇб³ 2-3ÇгâÀÌ µÇ¸é, ÀÌ Àå¾Ö°¡ ¶Ñ·ÇÇØÁø´Ù. »ê¼úÀÇ ±âº» °³³äÀÇ ½ÀµæÀÌ ¾î·Æ°í, ¼ýÀÚÀÇ »ó¡Àû Àǹ̳ª, ¼öÇÐÀû ¿ë¾î ¹× ±âÈ£ÀÇ ÀÌÇØ°¡ ¾î·Á¿ö, Àǹ̰¡ ÀÖ´Â ¼ÀÇϱⰡ ¾î·Æ°í, ±â¼ö¿Í ¼­¼öÀÇ ±¸º°ÀÌ ¾î·Æ´Ù. °è»ê Áß ÀûÀýÇÏ°Ô ¼ýÀÚ¸¦ Á¤·ÄÇϰųª ¼Ò¼öÁ¡À̳ª ºÎÈ£¸¦ ³¢¿ö ³Ö´Â »ê¼úÀû °è»êÀÇ °ø°£Àû Á¶Á÷ ´É·ÂÀÌ ¶³¾îÁø´Ù. Ä¡·á : Ư¼ö±³À°Àû Á¢±ÙÀÌ °¡Àå È¿°úÀûÀÌ´Ù. ÁÖÀÇ·Â °áÇÌ °úÀ× Çൿ Àå¾Ö³ª ¿ì¿ïÁõÀÌ µ¿¹ÝµÉ °æ¿ì, ¾à¹° Ä¡·á¿Í Á¤½Å Ä¡·á¸¦ ÇÔ²² ÇÑ´Ù. ¿¹¹æ : Á¶±â ¹ß°ßÀÌ ¿¹ÈÄ¿¡ ¸Å¿ì Áß¿äÇÏ´Ù.
  • learning mechanism
    ÇнÀ ±âÀü
  • learning process
    ÇнÀ °úÁ¤, ½Àµæ °úÁ¤
    ¹è¿ö¼­ ÀÍÈ÷´Â °úÁ¤, ´Ü°è.
  • A beta
    A º£Å¸, A º£Å¸ ½Å°æ ¼¶À¯
    Á¢ÃË, ¾Ð·Â, Áøµ¿ µî ´ëºÎºÐÀÇ Ã˰¢À» Àü´ÞÇÏ´Â ±½Àº À¯¼ö ½Å°æÀÌ´Ù. Á÷°æÀº 13-22§­, ½Å°æ Àü´Þ ¼Óµµ´Â 70-120§½ÀÌ´Ù.
  • A-beta fiber
    A-º£Å¸ ½Å°æ ¼¶À¯
    Á¢ÃË, ¾Ð·Â ÀÚ±ØÀ» Àü´ÞÇÏ´Â À¯¼ö ½Å°æÀÌ´Ù.
  • acetyl-beta-methylcholine
    ¾Æ¼¼Æ¿-º£Å¸-¸ÞÆ¿Äݸ°
  • beta
    ¥â
    hemolysis
  • beta
    º£Å¸
    ±×¸®½º¾î ¾ËÆÄºªÀÇ µÎ ¹øÂ° ¹®Àڷμ­ È­ÇÐ¸í¿¡ À־´Â 2°³ ÀÌ»óÀÇ À̼ºÃ¼ Áß Çϳª¸¦ Ç¥½ÃÇÏ´Â µ¥ »ç¿ëÇÑ´Ù. ¶ÇÇÑ È­ÇÕ¹°¿¡¼­ ġȯ ¿øÀÚ³ª ¿øÀÚ´ÜÀÇ À§Ä¡¸¦ Ç¥½ÃÇÏ´Â µ¥ »ç¿ëµÈ´Ù.
  • beta cell tumor
    º£Å¸ ¼¼Æ÷Á¾
  • beta hemolysis
    º£Å¸ ¿ëÇ÷, º£Å¸Çü ¿ëÇ÷
  • beta ray
    º£Å¸ ¼±
    ¹æ»ç¼± ¹°Áú¿¡¼­ ³ª¿À´Â ÀüÀÚ¼±À¸·Î ±¤¼ÓÀÇ 0.98¹èÀÇ ÃÖ´ë¼Óµµ¸¦ °¡Áø´Ù.
  • beta receptor blocker
    º£Å¸ ¼ö¿ëü Â÷´ÜÁ¦
  • beta test
    º£Å¸ ½ÃÇè
  • beta wave
    º£Å¸ ÆÄ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
androst-5-ene-3 beta,17 beta-diol <chemical> An adrenal-derived oestrogenic metabolite of dhea. Evidence exist for its use as an endocrine regulator of immune response.
Pharmacological action: anabolic steroids.
Chemical name: Androst-5-ene-3,17-diol, (3beta,17beta)-
(12 Dec 1998)
beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Capable of adding a glcnac residue to g1cnacman(3)g1cnac; from mung bean seedlings
Registry number: EC 2.4.1.146
Synonym: n-acetylglucosaminyltransferase II, gal3-(glcnac6)galnac-mucin (glcnac--gal)3-glcnactransferase
(26 Jun 1999)
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferase <enzyme> With EC 2.4.1.148 this is called beta6-glcnac-transferase b
Registry number: EC 2.4.1.102
Synonym: gal3-galnac-mucin-6-glcnac transferase, udp-glcnac-gal1-3galnac-r-(glcnac to galnac)-beta1-6glcnac transferase, core 2 glcnac transferase, core 2-n-acetylglucosaminyltransferase, core 2 beta6-gn-t
(26 Jun 1999)
beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase <enzyme> Induced in preneoplastic stage of liver carcinogenesis promoted by orotic acid in rats; adds "bisecting n-acetylglucosaminyl residue in beta 1,4 linkage to the beta-linked mannose of the core of asparagine-linked oligosaccharides
Registry number: EC 2.4.1.144
Synonym: n-acetylglucosaminyltransferase III, udpgnac-glycopeptide beta4-n-acetylglucosaminyl transferase III, udpgnac-magtransferase III, udp-n-acetylglucosamine-beta-d-mannoside beta-1,4-n-acetylglucosaminyltransferase III
(26 Jun 1999)
beta-hydroxy-beta-methylglutaryl-CoA -OOCCH2C(OH)(CH3)CH2COS-CoA;a key intermediate in the synthesis of ketone bodies and of steroids.
Synonym: 3-hydroxy-3-methylglutaryl-CoA.
Beta-hydroxy-beta-methylglutaryl-lyase, an enzyme, found primarily in liver and rumen epithelium that catalyses the formation of acetyl-CoA and acetoacetate from beta-hydroxy-beta-methylglutaryl-CoA; a key step in ketogenesis; a deficiency of this enzyme leads to episodes of severe metabolic acidosis without ketosis.
Beta-hydroxy-beta-methylglutaryl-reductase, an enzyme that catalyses the rate-limiting step of cholesterol biosynthesis, beta-hydroxy-beta-methylglutaryl-CoA + 2NADPH + 2H+ &rarr; mevalonate + 2NADP+ + coenzyme A.
Beta-hydroxy-beta-methylglutaryl-synthase, an enzyme in mitochondria that catalyses the reaction of acetyl-CoA with acetoacetyl-CoA and water to form beta-hydroxy-beta-methylglutaryl-CoA and coenzyme A, a step required for both ketogenesis and steroidogenesis to occur.
(05 Mar 2000)
beta-n-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase <enzyme> An enzyme that catalyses the transfer of galactose from udp-galactose to a specific glycoprotein receptor, 2-acetamido-2-deoxy-d-glucosyl-glycopeptide, during glycopeptide synthesis.
Chemical name: UDPgalactose:N-acetyl-beta-D-glucosaminylglycopeptide beta-1,4-galactosyltransferase
Registry number: EC 2.4.1.38
(12 Dec 1998)
beta, or beta-value <radiobiology> Ratio of plasma kinetic pressure to magnetic-field pressure, proportional to the ratio of plasma kinetic energy density to magnetic field energy density. Beta is usually measured relative to the total, local field (loosely called beta toroidal), but sometimes the plasma pressure relative to only the poloidal component of the field (beta poloidal) or relative to some external field (like the maximum field at the magnetic coils) is more useful. There is also a normalised beta (beta_N) of interest when discussing the beta limit. (lots of help from Art Carlson with the above.) Because the cost of a reactor is strongly influenced by the strength of the magnetic field that must be provided, beta values are directly related to the economics of fusion power production. Beta is usually expressed as a percentage, with 5% generally believed to be the minimum value required for an economical fusion reactor.
See: pressure, kinetic pressure, magnetic pressure, second stability.
(09 Oct 1997)
UDP-GalNAc-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase <enzyme> Consider also EC 2.4.1.92
Registry number: EC 2.4.1.-
Synonym: beta-1,4-n-acetylgalactosaminyltransferase, 4-galnactransferase, udp-n-acetylgalactosamine-beta-galactose beta 1,4-n-acetylgalactosaminyltransferase, (1-4)-n-acetyl-beta-d-galactosaminyltransferase, galnact-1
(26 Jun 1999)
5 alpha-androstane-3 beta,17 beta-diol 6 alpha-hydroxylase <enzyme> Requires NADPH, found in rat prostatic microsomes
Registry number: EC 1.14.13.-
Synonym: artdl 6 alpha-hydroxylase
(26 Jun 1999)
5 alpha-androstane 3 beta,17 beta-diol 7 alpha-hydroxylase <enzyme> Requires NADPH, found in rat prostate microsomes
Registry number: EC 1.14.13.-
Synonym: artdl 7 alpha-hydroxylase
(26 Jun 1999)
association learning The principle that items experienced together enter into a connection, so that one tends to reinstate the other.
(12 Dec 1998)
avoidance learning A response to a cue that is instrumental in avoiding a noxious experience.
(12 Dec 1998)
machine learning This is the study of how to create computers that will learn from experience and modify their activity based on that learning (as opposed to traditional computers whose activity will not change unless the programmer explicitly changes it). This discipline is a sub-set of Artificial Intelligence.
(09 Oct 1997)
paired-associate learning Learning in which the subject must respond with one word or syllable when presented with another word or syllable.
(12 Dec 1998)
verbal learning Learning to respond verbally to a verbal stimulus cue.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta
    º£Å¸
  • Phi Beta Kappa
    ÆÄÀÌ.º£Å¸.Ä«ÆÄŬ·´
  • beta
    º£Å¸(±×¸®½º¾î ¾ËÆÄºªÀÇ µÑ° ÀÚ)
  • beta minus
    2·ùÀÇÇÏ;2·ùº¸´Ù Á» ¸øÇÑ
  • beta particle
    º£Å¸ÀÔÀÚ
  • beta rays
    º£Å¸¼±
  • beta rhythm
    º£Å¸¸®µë(¸ÅÃÊ 10ÀÌ»óÀÇ ³úÆÄÀÇ ¹éµ¿)
  • learning
    Çй®
  • New Learning
    ½ÅÇй®;Çп¹ ºÎÈï(¹®¿¹ºÎÈïÀÇ ÀÚ±ØÀ» ¹Þ°í ÀϾ °í´ë ±×¸®½º ¹®¿¹ÀÇ ¿¬±¸)
  • computer-based learning
    ÄÄÇ»Å͸¦ ÇнÀÀÇ µµ±¸·Î ÀÌ¿ëÇϱâ
  • electronic learning
    ÀüÀÚ ÇнÀ(ÄÄÇ»Å͸¦ »ç¿ëÇÑ ÇнÀ)
  • learning
    Çй®;¹Ú½Ä;man of ~ing ÇÐ½Ä ÀÖ´Â »ç¶÷
  • mastery learning
    ¿ÏÀü ½Àµæ ÇнÀ
  • paired-associate learning
    ¿¬»ó ÇнÀ ¹æ½Ä(¼ýÀÚ,´Ü¾î,±×¸² µîÀ» ¦À» Áö¾î¼­ ¿¬»ó¿¡ ÀÇÇØ ±â¾ïÇÏ´Â ¹æ½Ä)
  • programmed learning
    ÇÁ·Î±×·¥ ÇнÀ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á